Interaction of MRE11 and Clinicopathologic Characteristics in Recurrence of Breast Cancer: Individual and Cumulated Receiver Operating Characteristic Analyses

Table 5

Risk relationship of scores with selected variables.

Score	Total	Age ≥ 52 yrs; ()		PR negative; ()		MRE11 positive cells > 50%; ()		BMI ≥ 24; ()		HER2 negative; ()
			%		%		%		%		%
≤5	161	51	31.68	47	29.19	61	37.89	96	59.63	103	63.98
6	43	27	62.79	27	62.79	20	46.51	32	74.42	27	62.79
7	24	18	75.00	16	66.67	13	54.17	24	100.00	14	58.33
8	17	13	76.47	13	76.47	12	70.59	15	88.24	13	76.47
9	8	7	87.50	8	100.00	6	75.00	8	100.00	6	75.00
10	1	1	100.00	1	100.00	1	100.00	1	100.00	1	100.00

PR: progesterone receptor; MRE11: meiotic recombination 11; BMI: body mass index; HER2: human epidermal growth factor receptor 2.
Dataset was retrieved from our previous study () [9].
Cumulated score representing the number of risk properties of the selected clinicopathologic variables in the subjects. The selected clinicopathologic variables included tumor size, tumor stage, ER, HT, LN metastasis, age, PR, BMI, MRE11 positive cells, and HER2.